AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14615303 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional dissociation between first- and second-order motion
Number of subjects: 0
Study 10815854 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone therapy
Number of subjects: 25
Study 10815854 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 25
Study 10815854 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciglitazone and 15-deoxy-delta-12,14-prostaglandinJ2
Number of subjects: 25
Study 8986924 — intervention group
Group type: EXPERIMENTAL
Intervention: Office blood pressure measured in winter and summer
Number of subjects: 50
Study 8986924 — intervention group
Group type: EXPERIMENTAL
Intervention: Home blood pressure measured in winter and summer
Number of subjects: 50
Study 8986924 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure measured in winter and summer
Number of subjects: 50
Study 8986924 — intervention group
Group type: EXPERIMENTAL
Intervention: Night-time ambulatory blood pressure measured in winter and summer
Number of subjects: 50
Study 8986924 — intervention group
Group type: EXPERIMENTAL
Intervention: Average 24 h blood pressure measured in winter and summer
Number of subjects: 50
Study 1479419 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular recombinant alpha 2b interferon (3 x 10(6)) administered every second evening for 6 months
Number of subjects: 70
Study 1479419 — intervention group
Group type: COMPARATOR
Intervention: Aspecific treatment
Number of subjects: 70
Study 6335848 — intervention group
Group type: EXPERIMENTAL
Intervention: Two diphtheria‐pertussis‐tetanus (DPT) immunizations 6 months apart
Number of subjects: 902
Study 6335848 — intervention group
Group type: COMPARATOR
Intervention: Conventional three doses of DPT 3 months apart
Number of subjects: 902
Study 6335848 — intervention group
Group type: EXPERIMENTAL
Intervention: Both immunized groups (2-dose and 3-dose)
Number of subjects: 902
Study 6335848 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial children (both immunized groups)
Number of subjects: 902
Study 31215198 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counselling group (NCG) - kickboxers
Number of subjects: 40
Study 31215198 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counselling group (NCG) - runners
Number of subjects: 40
Study 31215198 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - kickboxers
Number of subjects: 40
Study 31215198 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - runners
Number of subjects: 40
Study 30103079 — intervention group
Group type: EXPERIMENTAL
Intervention: Older-centered Integrated Health Management Model Project (OPCHMP), personalized, 2-year intervention
Number of subjects: 637
Study 30103079 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 637
Study 30103079 — intervention group
Group type: EXPERIMENTAL
Intervention: Older-centered Integrated Health Management Model Project (OPCHMP)
Number of subjects: 637
Study 26203971 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective earplugs
Number of subjects: 144
Study 26203971 — intervention group
Group type: EXPERIMENTAL
Intervention: Less effective earplugs
Number of subjects: 144
Study 26203971 — intervention group
Group type: COMPARATOR
Intervention: No earplugs
Number of subjects: 144
Study 26203971 — intervention group
Group type: EXPERIMENTAL
Intervention: Active noise cancellation headphones with sound masking
Number of subjects: 144
Study 26203971 — intervention group
Group type: EXPERIMENTAL
Intervention: Active noise cancellation headphones without sound masking
Number of subjects: 144
Study 24161018 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir plus tenofovir/emtricitabine (arm A)
Number of subjects: 40
Study 24161018 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir/lamivudine (arm B)
Number of subjects: 40
Study 22410206 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (SNRI)
Number of subjects: 483
Study 22410206 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (SSRI)
Number of subjects: 483
Study 20304399 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-measured maximum tumor thickness (MTT) after CRT < or = 6 mm
Number of subjects: 56
Study 20304399 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-measured relative reduction in MTT (yMTT/MTT) < or = 50%
Number of subjects: 56
Study 20304399 — intervention group
Group type: EXPERIMENTAL
Intervention: yMTT
Number of subjects: 56
Study 20304399 — intervention group
Group type: EXPERIMENTAL
Intervention: yMTT < or = 6 mm and yMTT/MTT < or = 50%
Number of subjects: 56
Study 18055682 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured screening instrument conducted at ages 15/18 and 24 months
Number of subjects: 9419
Study 18055682 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 9419
Study 16254767 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral guided self-care
Number of subjects: 85
Study 16254767 — intervention group
Group type: COMPARATOR
Intervention: Family therapy
Number of subjects: 85
Study 12030726 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg Turbuhaler)
Number of subjects: 25
Study 12030726 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (50 microg Diskus)
Number of subjects: 25
Study 12030726 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (500 microg Turbuhaler)
Number of subjects: 25
Study 12030726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 9672328 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 75 mg/day
Number of subjects: 24
Study 9672328 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 4000 mg/day
Number of subjects: 24
Study 9672328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8032383 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser assisted hatching
Number of subjects: 0
Study 8032383 — intervention group
Group type: COMPARATOR
Intervention: Control group (mechanical SUZI)
Number of subjects: 0
Study 8032383 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 8032383 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser assisted micromanipulation (SUZI)
Number of subjects: 0
Study 8032383 — intervention group
Group type: COMPARATOR
Intervention: Mechanical SUZI
Number of subjects: 0
Study 8032383 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser (PZD)
Number of subjects: 0
Study 8032383 — intervention group
Group type: COMPARATOR
Intervention: Mechanical (PZD)
Number of subjects: 0
Study 2643088 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy-listening music
Number of subjects: 10
Study 2643088 — intervention group
Group type: EXPERIMENTAL
Intervention: Rock music
Number of subjects: 10
Study 2643088 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected music
Number of subjects: 10
Study 2643088 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissertation (placebo-attention)
Number of subjects: 10
Study 2643088 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 10
Study 2643088 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-generated imagery with music (SIM)
Number of subjects: 10
Study 2643088 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery with music (GIM)
Number of subjects: 10
Study 2643088 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-generated imagery without music (SI)
Number of subjects: 10
Study 2643088 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery without music (GI)
Number of subjects: 10
Study 787518 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 100 mg
Number of subjects: 18
Study 787518 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 18
Study 787518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31326480 — intervention group
Group type: EXPERIMENTAL
Intervention: PET MPI
Number of subjects: 322
Study 31326480 — intervention group
Group type: COMPARATOR
Intervention: SPECT MPI
Number of subjects: 322
Study 28222674 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.4 administration
Number of subjects: 120
Study 28222674 — intervention group
Group type: COMPARATOR
Intervention: Sodium lactate Ringer's solution 7.5 mL/kg
Number of subjects: 120
Study 26228686 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT) through the small saphenous vein (Group A)
Number of subjects: 106
Study 26228686 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT) through the great saphenous vein (Group B)
Number of subjects: 106
Study 26228686 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT) through the popliteal vein (Group C)
Number of subjects: 106
Study 26228686 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of 88 patients for 7-24 months
Number of subjects: 106
Study 24194421 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (daily 25 mg)
Number of subjects: 94
Study 23031470 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g FB/kg DM diet
Number of subjects: 24
Study 23031470 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 g FB/kg DM diet
Number of subjects: 24
Study 23031470 — intervention group
Group type: COMPARATOR
Intervention: Control (0 g FB/kg DM diet)
Number of subjects: 24
Study 23031470 — intervention group
Group type: COMPARATOR
Intervention: 50 g FB/kg DM diet
Number of subjects: 24
Study 23031470 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest level of FB (150 g FB/kg DM diet)
Number of subjects: 24
Study 23031470 — intervention group
Group type: EXPERIMENTAL
Intervention: All FB diets
Number of subjects: 24
Study 19435954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy using a closed-loop system (AP group)
Number of subjects: 0
Study 19435954 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin therapy using the sliding-scale method (SS group)
Number of subjects: 0
Study 17302746 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% luliconazole cream
Number of subjects: 241
Study 17302746 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% luliconazole cream
Number of subjects: 241
Study 17302746 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% luliconazole cream
Number of subjects: 241
Study 15366590 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuizhitong capsule (SZT)
Number of subjects: 85
Study 15366590 — intervention group
Group type: COMPARATOR
Intervention: Piracetam
Number of subjects: 85
Study 11411424 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger adults
Number of subjects: 0
Study 11411424 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 0
Study 10093804 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic tourniquet (T)
Number of subjects: 32
Study 10093804 — intervention group
Group type: COMPARATOR
Intervention: No tourniquet (NT)
Number of subjects: 32
Study 7811481 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservation of annulo-papillary continuity (PAPC) during mitral valve replacement
Number of subjects: 69
Study 7811481 — intervention group
Group type: COMPARATOR
Intervention: Excision of all the chordae (EC) during mitral valve replacement
Number of subjects: 69
Study 3406428 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceruletide (0.8 micrograms/kg/week)
Number of subjects: 8
Study 3406428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1827011 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine MR 5 mg once daily
Number of subjects: 32
Study 1827011 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine MR 10 mg once daily
Number of subjects: 32
Study 1827011 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine given twice daily (13 +/- 2 mg total daily dose)
Number of subjects: 32
Study 1827011 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-release isradipine (isradipine MR) once daily
Number of subjects: 32
Study 766142 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg
Number of subjects: 0
Study 766142 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 3 mg
Number of subjects: 0
Study 766142 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 0
Study 30608465 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission packets used to guide nurses' first home visit after hospital discharge
Number of subjects: 20
Study 30608465 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-generated medication lists in admission packets
Number of subjects: 20
Study 28667499 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage Turnbull-Cutait coloanal anastomosis
Number of subjects: 0
Study 28667499 — intervention group
Group type: COMPARATOR
Intervention: Hand-sewn coloanal anastomosis with associated lateral ileostomy
Number of subjects: 0
Study 26197289 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex PCR assay
Number of subjects: 230
Study 26197289 — intervention group
Group type: COMPARATOR
Intervention: Multiplex PCR compared to culture method
Number of subjects: 230
Study 24558079 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 0
Study 24558079 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study 24558079 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21330250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobalt-chromium drug-eluting stents
Number of subjects: 11313
Study 21330250 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel drug-eluting stents
Number of subjects: 11313
Study 19183164 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with a quantified peach extract for Pru p 3, duration: 6 months
Number of subjects: 0
Study 19183164 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19183164 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with a quantified peach extract for Pru p 3
Number of subjects: 0
Study 17272521 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision screening in the office
Number of subjects: 0
Study 17272521 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision screening
Number of subjects: 0
Study 15277165 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g/d)
Number of subjects: 168
Study 15277165 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactation
Number of subjects: 168
Study 15277165 — intervention group
Group type: COMPARATOR
Intervention: Nonlactating status
Number of subjects: 168
Study 15277165 — intervention group
Group type: COMPARATOR
Intervention: Previous lactation status
Number of subjects: 168
Study 11808847 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (16 IU) administered intranasally to 49 subjects
Number of subjects: 103
Study 11808847 — intervention group
Group type: COMPARATOR
Intervention: Control group of 54 subjects with no prior oxytocin treatment
Number of subjects: 103
Study 9735932 — intervention group
Group type: EXPERIMENTAL
Intervention: Microencapsulated lambdacyhalothrin for bednet treatment
Number of subjects: 240
Study 9735932 — intervention group
Group type: EXPERIMENTAL
Intervention: Microencapsulated lambdacyhalothrin for house spraying
Number of subjects: 240
Study 9735932 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 240
Study 9735932 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (bednet and house spraying)
Number of subjects: 240
Study 7852746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 2902642 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuclopenthixol decanoate injection (mean dosage 123 mg/week)
Number of subjects: 116
Study 2902642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 30427829 — intervention group
Group type: EXPERIMENTAL
Intervention: rcAd26.MOS1.HIV‐Env vaccine (10^8 to 10^11 rcAd26 VP)
Number of subjects: 22
Study 30427829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 25374187 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (4,500 cGy of radiation at 180 cGy per day plus chemotherapy with cisplatin and 5‐fluorouracil, in the first and the end four days of radiotherapy)
Number of subjects: 25
Study 25374187 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemoradiotherapy after surgical resection
Number of subjects: 25
Study 25374187 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemoradiotherapy for well differentiated adenocarcinoma
Number of subjects: 25
Study 22330020 — intervention group
Group type: EXPERIMENTAL
Intervention: PRET at RPE13 for 30 min, 3 times per week for 8 weeks
Number of subjects: 26
Study 22330020 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study 20732940 — intervention group
Group type: EXPERIMENTAL
Intervention: Media Detective program
Number of subjects: 679
Study 20732940 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 679
Study 17981439 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (40 g daily for 12 months)
Number of subjects: 199
Study 17981439 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed
Number of subjects: 199
Study 17981439 — intervention group
Group type: COMPARATOR
Intervention: Wheat germ (placebo)
Number of subjects: 199
Study 17981439 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 199
Study 15514916 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids as part of antileukemic therapy
Number of subjects: 1951
Study 12351462 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide (4 mg t.i.d.)
Number of subjects: 80
Study 12351462 — intervention group
Group type: COMPARATOR
Intervention: Metformin (850 or 1,000 mg t.i.d., dose unchanged)
Number of subjects: 80
Study 12564024 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL)
Number of subjects: 117
Study 12564024 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug treatment
Number of subjects: 117
Study 8897218 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation with suggestions to increase immune system proteins
Number of subjects: 90
Study 8897218 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation alone
Number of subjects: 90
Study 8897218 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 90
Study 2003706 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone with usual diet
Number of subjects: 697
Study 2003706 — intervention group
Group type: COMPARATOR
Intervention: Placebo with usual diet
Number of subjects: 697
Study 2003706 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol with usual diet
Number of subjects: 697
Study 2003706 — intervention group
Group type: COMPARATOR
Intervention: Low-sodium diet with placebo
Number of subjects: 697
Study 2003706 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet with chlorthalidone
Number of subjects: 697
Study 2003706 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss diet
Number of subjects: 697
Study 6732567 — intervention group
Group type: EXPERIMENTAL
Intervention: Humphrey automatic refractor
Number of subjects: 100
Study 6732567 — intervention group
Group type: COMPARATOR
Intervention: Standard subjective techniques
Number of subjects: 100
Study 30126325 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/Phenylephrine administered with a nasal nebulizer
Number of subjects: 106
Study 30126325 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine/Phenylephrine administered with a nasal spray
Number of subjects: 106
Study 26685718 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 30
Study 26685718 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 30
Study 24533048 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) 80 ppm
Number of subjects: 40
Study 23059166 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR (extended-release)
Number of subjects: 139
Study 23059166 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine IR (immediate-release)
Number of subjects: 139
Study 23059166 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 139
Study 23059166 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine IR
Number of subjects: 139
Study 20371128 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochloride pioglitazone (group DP)
Number of subjects: 98
Study 20371128 — intervention group
Group type: COMPARATOR
Intervention: Sulfonylureas (group DS)
Number of subjects: 98
Study 18022467 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine (A100)
Number of subjects: 50
Study 18022467 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:200,000 epinephrine (A200)
Number of subjects: 50
Study 16792320 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin in the dose of 3 ppm KIU
Number of subjects: 109
Study 16792320 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 109
Study 12734059 — intervention group
Group type: EXPERIMENTAL
Intervention: High folate intake (highest tertile)
Number of subjects: 177
Study 12734059 — intervention group
Group type: COMPARATOR
Intervention: Lowest tertile of folate intake
Number of subjects: 177
Study 10410585 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF
Number of subjects: 71
Study 10410585 — intervention group
Group type: COMPARATOR
Intervention: GM‐CSF
Number of subjects: 71
Study 8533869 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (NP) infusion for 60 min, decreasing mean arterial blood pressure to 50 mm Hg.
Number of subjects: 30
Study 8533869 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NP infusion).
Number of subjects: 30
Study 8533869 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (NP) infusion for 60 min.
Number of subjects: 30
Study 2210311 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium-aspartate hydrochloride 15 mmol per day
Number of subjects: 568